J
Jacques Ferlay
Researcher at International Agency for Research on Cancer
Publications - 145
Citations - 276378
Jacques Ferlay is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 69, co-authored 129 publications receiving 211074 citations.
Papers
More filters
Journal ArticleDOI
Trends in oesophageal cancer incidence and mortality in Europe.
Cristina Bosetti,Fabio Levi,Jacques Ferlay,Werner Garavello,Werner Garavello,Franca Lucchini,Paola Bertuccio,Eva Negri,Carlo La Vecchia,Carlo La Vecchia +9 more
TL;DR: To monitor recent trends in mortality from oesophageal cancer in 33 European countries, the data provided by the World Health Organization over the last 2 decades were analyzed using joinpoint regression and Squamous‐cell carcinoma remained the prevalent histological type in southern Europe.
Journal ArticleDOI
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
TL;DR: These updated estimates of the global burden of oesophageal and gastric cancer by subtype and site suggest an ongoing transition in epidemiological patterns and will aid in developing appropriate cancer control strategies.
Journal ArticleDOI
Cancer in Africa 2012
TL;DR: With the number of annual cancer cases and deaths likely to increase by at least 70% by 2030, there is a pressing need for a coordinated approach to improving the extent and quality of services for cancer control in Africa, and better surveillance systems with which they can be planned and monitored.
Journal ArticleDOI
Epidemiology of biliary tract cancers: an update
Giorgia Randi,Giorgia Randi,Matteo Malvezzi,Matteo Malvezzi,Fabio Levi,Jacques Ferlay,Eva Negri,Silvia Franceschi,C. La Vecchia,C. La Vecchia +9 more
TL;DR: The decreasing BTC mortality trends essentially reflect more widespread and earlier adoption of cholecystectomy in several countries, since gallstones are the major risk factor for BTC.
Journal ArticleDOI
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group
Cindy Ke Zhou,David P. Check,Joannie Lortet-Tieulent,Mathieu Laversanne,Ahmedin Jemal,Jacques Ferlay,Freddie Bray,Michael B. Cook,Susan S. Devesa +8 more
TL;DR: Global geographic variation remained substantial for both overall and age‐specific incidence rates regardless of levels of PSA testing, with the lowest rates consistently in Asia.